AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Anterior Segment Anatomy Assessed by Swept-Source OCT in Ocular Surgery Patients

Recruitingn/aAges 18 Years - 90 YearsAllNanfang Hospital, Southern Medical University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This observational study aims to evaluate ocular anatomical parameters in patients undergoing anterior segment surgery using swept-source optical coherence tomography (SS-OCT). Anterior segment surgery, including procedures involving the cornea, lens, and other anterior eye structures, may be associated with changes in ocular anatomy. SS-OCT is a non-invasive imaging technique that provides detailed images of the anterior structures of the eye and allows quantitative assessment of ocular anatomical parameters. Patients undergoing anterior segment surgery at Nanfang Hospital, Southern Medical University, will be included in this study. SS-OCT will be used to assess ocular anatomical parameters, and the collected measurements will be analyzed to characterize anatomical features and explore potential differences among patients undergoing different types of anterior segment surgery. The f

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Voluntary provision of written informed consent. * 18โ‰คAgeโ‰ค90 years. * Patients diagnosed by an ophthalmologist with cataract, primary angle-closure disease, or other anterior segment disorders requiring anterior segment surgery. * Availability of complete or accessible preoperative and postoperative clinical records and ophthalmic examination data. Exclusion Criteria: * Follow-up duration of less than 3 months. * Substantial missing ophthalmic examination or perioperative data that prevents the required study analyses. * Inability to obtain valid anterior segment imaging data due to severe corneal opacity, poor ocular fixation, inadequate cooperation, or other related factors. * Presence of severe ocular trauma, intraocular tumors, severe corneal disease, active intraocular inflammation, or other ocular conditions that may substantially affect anterior segment structural assessment. * History of complex intraocular surgery that may significantly alter anterior segment anatomy and is considered unsuitable for inclusion by the investigator. * Other conditions considered by the investigator to make the patient unsuitable for participation in the study.
๐Ÿ’Š

What it tests

  • Ocular anatomical parameters will be measured using a swept-source optical coherence tomography (SS-OCT) device (CASIA2; Tomey Corporation, Nagoya, Japan). The imaging examination will be used to asse
๐Ÿ“

Where

1 site
Nanfang Hospital, Southern Medical University
Guangzhou, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy